LEADER 02081nam  2200385   450 
001 9910674377103321
005 20230624070636.0
024 7 $a10.3390/books978-3-0365-2925-7
035   $a(CKB)5400000000043767
035   $a(NjHacI)995400000000043767
035   $a(EXLCZ)995400000000043767
100   $a20230624d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNewborn Screening in Japan /$fedited by Toshihiro Tajima, Seiji Yamaguchi
210  1$aBasel, Switzerland :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2022.
215   $a1 online resource (116 pages)
311   $a3-0365-2924-1 
330   $a"Newborn Screening in Japan--2021" is a topical collection of the International Journal of Neonatal Screening. Japan's newborn mass screening (NBS) was started in 1977 at the national level as a national project. Subsequently, screening was conducted for six diseases. From 2014 a tandem mass analyzer (tandem mass) was introduced nationwide, and in addition to the conventional amino acid metabolism disorders urea cycle disorders, organic acid metabolism disorders and fatty acid metabolism disorders have joined the target diseases. Screening is currently conducted for 20 diseases. The acceptance rate of mass screening in Japan is 100%, and top-level screening measures available in the world, such as a quality control system and an inspection system, are carried out. This book is an overview of the history, current status and future of NBS in Japan. I hope that readers are interested in this book.
606   $aChildren$xDiseases$xDiagnosis
606   $aMedical screening$zUnited States
615  0$aChildren$xDiseases$xDiagnosis.
615  0$aMedical screening
676   $a362.177
702   $aTajima$b Toshihiro
702   $aYamaguchi$b Seiji
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910674377103321
996   $aNewborn Screening in Japan$92943943
997   $aUNINA